Literature DB >> 17168645

Genetic and environmental modifiers of Alzheimer's disease phenotypes in the mouse.

Davis Ryman1, Bruce T Lamb.   

Abstract

As a group, strains of laboratory mice carrying Alzheimer's disease (AD)-related transgenes are currently the most widely studied animal models of AD. Many AD mouse models carrying the same or similar transgene constructs demonstrate strikingly different phenotypic responses to transgene expression, mimicking the apparent genetic complexity of AD pathogenesis seen in the human population. Genetic differences between the numerous mouse model strains used for AD research can significantly affect correct interpretation and cross-comparison of experimental findings, making genetic background an important consideration for all work in mouse models of AD. Furthermore, because of the potential for discovering novel genetic modifiers of AD pathogenesis, the effects of genetic background on AD phenotypes in the mouse can prove a worthwhile subject of study in their own right. This review discusses the implications of genetic modifiers for mouse and human AD research, and summarizes recent findings identifying significant roles for genetic background in modifying important phenotypes in AD mouse models, including premature death, amyloid deposition, tau hyperphosphorylation, and responsiveness to environmental or treatment interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17168645     DOI: 10.2174/156720506779025198

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  18 in total

1.  Vildagliptine protects SH-SY5Y human neuron-like cells from Aβ 1-42 induced toxicity, in vitro.

Authors:  Alim Hüseyin Dokumacı; Mukerrem Betul Yerer Aycan
Journal:  Cytotechnology       Date:  2019-04-09       Impact factor: 2.058

2.  Are Sema5a mutant mice a good model of autism? A behavioral analysis of sensory systems, emotionality and cognition.

Authors:  Rhian K Gunn; Matthew J Huentelman; Richard E Brown
Journal:  Behav Brain Res       Date:  2011-07-12       Impact factor: 3.332

Review 3.  Animal models of human amyloidoses: are transgenic mice worth the time and trouble?

Authors:  Joel N Buxbaum
Journal:  FEBS Lett       Date:  2009-07-20       Impact factor: 4.124

4.  Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.

Authors:  Brian A Couch; Meghan E Kerrisk; Adam C Kaufman; Haakon B Nygaard; Stephen M Strittmatter; Anthony J Koleske
Journal:  J Comp Neurol       Date:  2013-04-15       Impact factor: 3.215

Review 5.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

6.  Of mice and men: bridging the translational disconnect in CNS drug discovery.

Authors:  Hugo Geerts
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

7.  Chemical and morphological alterations of spines within the hippocampus and entorhinal cortex precede the onset of Alzheimer's disease pathology in double knock-in mice.

Authors:  Chiye Aoki; Veeravan Mahadomrongkul; Sho Fujisawa; Rebecca Habersat; Tomoaki Shirao
Journal:  J Comp Neurol       Date:  2007-12-01       Impact factor: 3.215

8.  Expression of galectins-1, -3 and -4 varies with strain and type of experimental colitis in mice.

Authors:  Anne Mathieu; Nathalie Nagy; Christine Decaestecker; Liesbeth Ferdinande; Klaas Vandenbroucke; Pieter Rottiers; Claude A Cuvelier; Isabelle Salmon; Pieter Demetter
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

Review 9.  The paradox of syndromic diversity in Alzheimer disease.

Authors:  Jason D Warren; Phillip D Fletcher; Hannah L Golden
Journal:  Nat Rev Neurol       Date:  2012-07-17       Impact factor: 42.937

10.  Comparative transcriptome profiling of amyloid precursor protein family members in the adult cortex.

Authors:  Dorothee Aydin; Mikhail A Filippov; Jakob-Andreas Tschäpe; Norbert Gretz; Marco Prinz; Roland Eils; Benedikt Brors; Ulrike C Müller
Journal:  BMC Genomics       Date:  2011-03-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.